Article Text


AB0101 Transverse myelitis: a rare manifestation of behÇet’s disease
  1. C Macieira,
  2. C Miranda Rosa,
  3. JC Teixeira da Costa,
  4. M Viana Queiróz
  1. Unit of Rheumatology and Metabolic Bone Diseases, Santa Maria Hospital, Lisbon, Portugal


Background The diagnosis of Behçet’s disease is based on well-known criteria. Although skin, eye and joints are the most frequently involved organs, other systems may be affected such as the nervous system. Transverse myelitis is a rare and serious manifestation of the disease.

We present the case of a 51 year-old woman with a 2 year diagnosis of Behçet’s disease, initially presented as oral aphtosis, genital ulcerations, symmetrical polyarthritis and a maculo-papular hand rash. Eye examination was normal.

The patient remained well for 2 years, when suddenly presented with severe headache, back pain, a rapidly progressive tetraparesia and a global sensitive deficit.

Erythrocyte sedimentation rate, C-reactive protein, total blood cell count, lisozyme, angiotensin-converting enzyme and complement factors were within the normal laboratory ranges. The serologic tests for rickettsial and Lyme?s diseases were negative. The immunological study was positive for anti-Scl70 antibody and lupus anticoagulant.

Cerebrospinal fluid analysis revealed a 48-cell count with predominance of mononuclear forms and normal cultural and pathology examinations.

Spinal cord magnetic resonance imaging (MRI) identified a cervico-thoracic lesion suggestive of transverse myelitis. The cranial MRI was normal.

Pulsed methylprednisolone (1 g/day) was initiated, with rapid clinical improvement. After 45 days, with a maintenance dose of prednisone (30 mg/day) the patient was doing well referring residual sensitive deficit. With a one-year follow-up and daily prednisone (20 mg) and azathioprine (50 mg), the patient is assymptomatic and there are no neurological sequelae.

A literature review was performed. Central nervous system involvement occurs in less than 5% of cases of Behcet’s disease and in this group 69% have clinical manifestations suggestive of transverse myelitis. High methylprednisolone doses are fundamental for favourable clinical outcome.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.